However, altered cytotoxic activity in AMs and tumour-associated macrophages (TAMs) has been shown to be mediated via decreased secretion of cytokines (IL-1, IL-6, and TNF-α) in patients with lung cancer [9, 15]. This evidence concerns the gene TNF and lung carcinoma.